Beijing [China], December 31 (ANI): Amid global criticism over the efficacy of the Sinopharm vaccine against COVID-19, China on Thursday approved the country's first coronavirus vaccine for general public use, reported New York Times (NYT).
Buenos Aires [Argentina], December 31 (ANI/Xinhua): Argentina's National Administration of Drugs, Foods and Medical Devices (ANMAT) on Wednesday approved the use of vaccine from AstraZeneca, a multinational pharmaceutical and biopharmaceutical company, against Covid-19 in the country.
Moscow [Russia], December 29 (ANI): Belarus has become the first country after Russia to begin vaccination of people with Sputnik-V against Covid-19, Russian Direct Investment Fund (RDIF) said on Tuesday.
Buenos Aires [Argentina], December 29 (ANI/Sputnik): Argentina will begin vaccinating its population against coronavirus on Tuesday, using Russia's Sputnik V vaccine.
Moscow [Russia], December 24 (ANI): As many as 300,000 doses of Russia's Sputnik V COVID-19 vaccine arrived in Argentina on Thursday morning, following its approval by the government for emergency use.
New Delhi [India], December 21 (ANI): Russia is working with India to jointly produce Sputnik V coronavirus vaccine at Dr Reddy's Laboratories for use in India, Russia and other countries, said Nikolay Kudashev, Russian Ambassador to India, on Monday.
Moscow [Russia], December 21 (ANI): Sputnik V, the world's first COVID-19 vaccine, will be "highly effective" against the new strain of coronavirus found in Europe, said Kirill Dmitriev, Chief Executive Officer (CEO) of Russian Direct Investment Fund, the company which codeveloped the vaccin
Moscow [Russia], December 18 (ANI): India will produce about 300 million doses of the Russian Sputnik V coronavirus vaccine in 2021, Head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said.
Moscow [Russia], December 17 (ANI): Sputnik V, the world's first COVID-19 vaccine, is over 95 per cent effective, said Russian President Vladimir Putin on Thursday.
Moscow [Russia], December 14 (ANI): The efficacy of the Sputnik V COVID-19 vaccine has been confirmed to be 91.4 per cent, based on data analysis of the final control point of clinical trials, announced the Gamaleya National Center of Epidemiology and Microbiology and the Russian Direct I
Moscow [Russia], December 11 (ANI/Sputnik): The developers of Russia's Sputnik V vaccine against coronavirus has expressed readiness to share its technology with France's Sanofi and the UK's GSK companies to help them with their vaccine development, the Russian vaccine's official Twitter acc
Moscow [Russia], December 11 (ANI/Sputnik): Crews of Russia's Navy and Aerospace Forces, combat squads of the Strategic Missile Forces, and doctors are the first in line to receive the Sputnik V vaccine against COVID-19, the Defense Ministry's spokesman Maj Gen Igor Konashenkov said.